Results 151 to 160 of about 3,235 (226)

Efficacy of tezepelumab in patients with severe, uncontrolled asthma and aspirin-exacerbated respiratory disease in NAVIGATOR.

Journal of Allergy and Clinical Immunology: In Practice
Tanya M. Laidlaw, K. Buchheit, Katherine Cahill, J. Bernstein, N. Martin, S. Roseti, Andrew W. Lindsley, C. Ambrose   +7 more
semanticscholar   +1 more source

Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma. [PDF]

J Allergy Clin Immunol Glob
Matsuno O, Kawashima K, Hanada Y, Wibowo T, Ishida Y, Ogata A.   +5 more
europepmc   +1 more source

Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient

Journal of Investigational Allergy and Clinical Immunology
S, Bautista-Villanueva, M, Mateos-Salvador, R, Arrojo Fuentes, M J, Rial   +3 more
openaire   +2 more sources

Impact of Biologics on Oscillometry Defined Small Airway Dysfunction in Uncontrolled Asthma. [PDF]

Clin Exp Allergy
Greig R, Suter P, Chan R, Lipworth B.
europepmc   +1 more source

Tezepelumab（抗TSLP抗体）

Japanese Journal of Allergology, 2021
openaire   +1 more source

Exploring type 2 inflammation and disease complexity: perspectives of a clinical immunologist. [PDF]

Front Immunol
Tal Y, Rubin L, Munitz A, Adini I.
europepmc   +1 more source

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort. [PDF]

J Pers Med
Nicola S, Negrini S, Ribolla F, Guida G, Rinaldo RF, Bondi B, Badiu I, Corradi F, Quinternetto A, Vitali I, Lo Sardo L, Crida B, Mhimid L, Tocci SL, Teocchi M, Milione A, Marengo M, Heffler E, Canonica GW, Blasi F, Paggiaro P, Boem M, Basiglio S, Alessi L, Braido F, Ricciardolo FLM, Solidoro P, Bagnasco D, Brussino L, On Behalf Of The Sani Study Group.   +29 more
europepmc   +1 more source

Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma. [PDF]

Clin Exp Allergy
Marriott H, Adatia A, Moitra S, Lacy P.
europepmc   +1 more source

Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. [PDF]

BMJ Open Respir Res
Burton R, Puthoor M, Fyles F, Lewis L, Joplin H, Burhan H.   +5 more
europepmc   +1 more source

Influence of PAI-1 gene polymorphism on the effectiveness of tezepelumab in individuals with severe asthma: a study protocol for a prospective, non-randomized, interventional, comparative trial. [PDF]

J Thorac Dis
Fukahori S, Obase Y, Fukushima C, Kosai K, Yanagihara K, Hara S, Tomari S, Tsubouchi H, Miyazaki T, Matsuo N, Matsuo A, Matsumoto N, Ide H, Tobino K, Kodaka N, Matsuse H, Arakaki W, Haranaga S, Yamamoto K, Yoshimine H, Sakakibara H, Yatera K, Tashiro H, Takahashi K, Himeji D, Mukae H.   +25 more
europepmc   +1 more source